Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-03-016095
Filing Date
2003-07-30
Accepted
2003-07-30 12:56:12
Documents
1
Period of Report
2003-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd14397.html 4  
1 FORM 4 rrd14397.xml 4 2235
  Complete submission text file 0001181431-03-016095.txt   4319
Mailing Address 31 ST JAMES AVE 8TH FL BOSTON MA 02116
Business Address 31 ST. JAMES AVENUE 8TH FLOOR BOSTON MA 02116 6174220674
GLYCOGENESYS INC (Issuer) CIK: 0000946661 (see all company filings)

EIN.: 330231238 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 12 APPLETON CIRCLE NEWTON MA 02459
Business Address 12 APPLETON CIRCLE NEWTON MA 02459
PLATT DAVID (Reporting) CIK: 0001166440 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26476 | Film No.: 03810783